Radiotherapy within 4 weeks prior to randomization, except as follows: Palliative radiation to target organs other than chest may be allowed up to 2 weeks prior to randomization, and Single dose palliative treatment for symptomatic metastasis outside above allowance to be discussed with sponsor prior to enrolling.